Eventuel systemisk påvirkning kan omfatte binyrebarksuppression, væksthæmning hos børn og unge, fald i knogletæthed, kararakt og glaukom (se pkt.
Increasing use of short-acting bronchodilators to relieve symptoms indicates deterioration of control and patients should be reviewed by a physician.